Capital Flow Monitor · Sponsors · CIK 1796240
Octagon Investments Fund LP
654 MADISON AVENUE, NEW YORK, NY, 10065 · 2123692829
Pooled Investment Fund / Hedge Fund · Limited Partnership· inc. DELAWARE true
Fit score
—
Offering
—
Sold
$380.1M
% sold
—
Investors
81
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-12-05 | D/A ·current | 506(b) | — | $380.1M | — | 81 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
n/a Octagon Investments GP, LLC — Executive Officer / Promoter, New York, NY
2 other raises
- Octagon Biotech Opportunities Offshore Fund II LP $53.9M of $175.0M · 30.8%
- Octagon Biotech Opportunities Fund II LP $17.8M of $175.0M · 10.2%
-
Ting Jia — Executive Officer / Promoter, New York, NY
1 other raise
- Octagon Investments Offshore Fund Ltd. $709.3M of —
-
n/a Octagon Capital Advisors LP — Promoter, New York, NY
3 other raises
- Octagon Biotech Opportunities Offshore Fund II LP $53.9M of $175.0M · 30.8%
- Octagon Biotech Opportunities Fund II LP $17.8M of $175.0M · 10.2%
- Octagon Investments Offshore Fund Ltd. $709.3M of —
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.